Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabiana Letizia Cecere

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Tumori|July 21, 2020
Ovarian metastasis from malignant pleural mesotheliomaGiuseppe Naldi, Serenella Bergomi, Paolo Visca, et al.
Journal of Geriatric Oncology|September 28, 2013
Medical treatment of advanced non-small cell lung cancer in elderly patients: a review of the role of chemotherapy and targeted agentsGiulia Meoni, Fabiana Letizia Cecere, Elisa Lucherini, et al.
Gynecologic Oncology Case Reports|December 28, 2013
Prolonged response to trabectedin in a heavily pretreated patient with metastatic endometrial carcinoma: A case report and literature reviewGiulia Meoni, Fabiana Letizia Cecere, Imane Chaib, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 26, 2007
Adjuvant chemotherapy for non-small cell lung cancerEmilio Bria, Federica Cuppone, Fabiana Letizia Cecere, et al.
Tumori|April 25, 2015
Outcome of crizotinib treatment in a young woman with heavily pretreated ROS1-positive lung cancerPaolo Petreni, Francesca Mazzoni, Giulia Meoni, et al.
Clinical and Experimental Medicine|November 17, 2025
Capmatinib for the treatment of METex14 skipping non-small cell lung cancer: retrospective analysis of real-world data from patients receiving compassionate use treatment in ItalyFabiana Letizia Cecere, Ettore D'Argento, Francesco Gelsomino, et al.
Lung Cancer (Amsterdam, Netherlands)|September 19, 2013
Phase II trial of customized first line chemotherapy according to ERCC1 and RRM1 SNPs in patients with advanced non-small-cell lung cancerFrancesca Mazzoni, Fabiana Letizia Cecere, Giulia Meoni, et al.
Frontiers in Oncology|November 29, 2023
Analysis of predictive factors of unforeseen nodal metastases in resected clinical stage I NSCLCFilippo Tommaso Gallina, Daniele Marinelli, Riccardo Tajè, et al.
Journal of Clinical Pathology|August 17, 2021
Not enough can be enough: feasibility of the Idylla <i>EGFR</i> mutation test when reuse of stained tissue slides is the only option availableCristiana Ercolani, Anna Di Benedetto, Claudia Bonomo, et al.
Journal of Clinical Medicine|April 23, 2022
Oncological Outcomes of Robotic Lobectomy and Radical Lymphadenectomy for Early-Stage Non-Small Cell Lung CancerFilippo Tommaso Gallina, Riccardo Tajè, Daniele Forcella, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Tumori|July 21, 2020
Ovarian metastasis from malignant pleural mesotheliomaGiuseppe Naldi, Serenella Bergomi, Paolo Visca, et al.
Journal of Geriatric Oncology|September 28, 2013
Medical treatment of advanced non-small cell lung cancer in elderly patients: a review of the role of chemotherapy and targeted agentsGiulia Meoni, Fabiana Letizia Cecere, Elisa Lucherini, et al.
Gynecologic Oncology Case Reports|December 28, 2013
Prolonged response to trabectedin in a heavily pretreated patient with metastatic endometrial carcinoma: A case report and literature reviewGiulia Meoni, Fabiana Letizia Cecere, Imane Chaib, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 26, 2007
Adjuvant chemotherapy for non-small cell lung cancerEmilio Bria, Federica Cuppone, Fabiana Letizia Cecere, et al.
Tumori|April 25, 2015
Outcome of crizotinib treatment in a young woman with heavily pretreated ROS1-positive lung cancerPaolo Petreni, Francesca Mazzoni, Giulia Meoni, et al.
Clinical and Experimental Medicine|November 17, 2025
Capmatinib for the treatment of METex14 skipping non-small cell lung cancer: retrospective analysis of real-world data from patients receiving compassionate use treatment in ItalyFabiana Letizia Cecere, Ettore D'Argento, Francesco Gelsomino, et al.
Lung Cancer (Amsterdam, Netherlands)|September 19, 2013
Phase II trial of customized first line chemotherapy according to ERCC1 and RRM1 SNPs in patients with advanced non-small-cell lung cancerFrancesca Mazzoni, Fabiana Letizia Cecere, Giulia Meoni, et al.
Frontiers in Oncology|November 29, 2023
Analysis of predictive factors of unforeseen nodal metastases in resected clinical stage I NSCLCFilippo Tommaso Gallina, Daniele Marinelli, Riccardo Tajè, et al.
Journal of Clinical Pathology|August 17, 2021
Not enough can be enough: feasibility of the Idylla <i>EGFR</i> mutation test when reuse of stained tissue slides is the only option availableCristiana Ercolani, Anna Di Benedetto, Claudia Bonomo, et al.
Journal of Clinical Medicine|April 23, 2022
Oncological Outcomes of Robotic Lobectomy and Radical Lymphadenectomy for Early-Stage Non-Small Cell Lung CancerFilippo Tommaso Gallina, Riccardo Tajè, Daniele Forcella, et al.
Pageof 4